Cegedim Relationship Management’s 3rd Annual US Pharma Insights Survey Reveals 74% of Pharma Execs Are Most Concerned About the Changing Commercial Business Model

<0> Survey Results Illustrate Strategic Evolutions in Business Models, Next Generation Tech Trends and Social Media </0>

Cegedim Relationship ManagementGlobal CommunicationsTel: +1 (908) 443.2451orCegedimMedia RelationsTel: +33 (0)1 49 09 68 81

today announced the release of its thought leadership report, , which provides the results of its third annual survey of life sciences decision makers on current challenges, upcoming business developments, preferred strategies and next generation technology. Leveraging analysis from three years of responses, the report delivers a holistic view of present and future trends.

Sustained industry concerns, evolved decision making leadership and new future strategies top 2012’s trends. Aligning with previous years’ responses, 74% of respondents ranked the changing commercial business model as their first, second or third priority of concern; followed by regulatory reform (62%) and market access (53%). Additionally, decision making leadership now sources from executive management for most technology decisions (46%); and strategy/business development for main business model/process changes (55%). Further, respondents clearly defined the following prioritized changes for the near future: increased focus on market access strategies (64%), primary sales force realignment (38%) and increased focus on managed markets (35%).

Surveyed executives cite continued focus on field centric tablet usage, their preferred mobile OS and social media. Eight out of ten (80%) currently use or will be using tablets, and unsurprisingly, field sales/account management (61%) account for the most active tablet users. Further, exactly half selected Apple OS as their favorite mobile platform. In terms of social media trending, the report underscores significant increases in usage between 2011 and 2012. LinkedIn (96%) and Facebook (70%) represent respondents’ leading channels with marketing (64%), PR (42%) and sales (38%) make up the most active departments. Lastly, despite minor social media budgets, those surveyed exhibited notable gains according to the report.

“The 2012 US report details exactly how and where our current industry climate is impacting strategy and operations. Respondents report strong focus on business model changes, as well as next generation and mobile technologies,” said Angela Miccoli, President of North America, Cegedim Relationship Management. “In order to further our standing as the leader in pharma CRM, data and compliance solutions, we strive to consistently monitor the pulse of the industry, and empower our customers with our proven insights and expertise.”

Cegedim Relationship Management, the global leader in Customer Relationship Management, Healthcare Data, Regulatory Compliance and Marketing Solutions for the Life Sciences industry, conducted the thought leadership survey in during the second half of 2012.

Apple is a registered trademark of Apple Inc. Other company and product names may be trademarks of their respective owners.

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.